Filing Details

Accession Number:
0001209191-16-129634
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-24 21:14:58
Reporting Period:
2016-06-23
Filing Date:
2016-06-24
Accepted Time:
2016-06-24 21:14:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850261 Sorrento Therapeutics Inc. SRNE Services-Commercial Physical & Biological Research (8731) 330344842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189020 Patrick Soon-Shiong 9922 Jefferson Boulevard
Culver City CA 90232
No No Yes No
1629186 Mp 13 Ventures, Llc 9922 Jefferson Boulevard
Culver City CA 90232
No No No Yes
1629222 Cambridge Equities, Lp 9922 Jefferson Boulevard
Culver City CA 90232
No No No Yes
1668335 Foundation Family Soon-Shiong Chan 9922 Jefferson Boulevard
Culver City CA 90232
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-06-23 6,901 $5.85 7,161,324 No 4 S Indirect Through The Chan Soon-Shiong Family Foundation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Through The Chan Soon-Shiong Family Foundation
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 720,174 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant $5.80 2014-12-22 2017-12-22 1,724,138 1,724,138 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-12-22 1,724,138 1,724,138 Indirect
Footnotes
  1. These shares of common stock were sold on the open market. The price reported in Column 4 is a weighted average sale price. Dr. Patrick Soon-Shiong undertakes to provide to Sorrento Therapeutics, Inc. (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the price at which these shares were sold.
  2. Dr. Patrick Soon-Shiong is the Chairman of The Chan Soon-Shiong Family Foundation.
  3. The exercise price of the Warrant is subject to customary adjustment provisions for stock splits, stock dividends, recapitalizations and the like.
  4. Dr. Patrick Soon-Shiong is the sole member of MP 13 Ventures, LLC, which is the general partner of Cambridge Equities, LP.